Galapagos NV (GLPG)
NASDAQ: GLPG · IEX Real-Time Price · USD
27.48
+0.09 (0.33%)
At close: Jul 26, 2024, 4:00 PM
27.45
-0.04 (-0.13%)
After-hours: Jul 26, 2024, 4:00 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.81 billion as of July 26, 2024. Its market cap has decreased by -33.69% in one year.
Market Cap
1.81B
Enterprise Value
-2.04B
1-Year Change
-33.69%
Ranking
Category
Stock Price
$27.48
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has decreased from $1.86B to $1.81B, a decrease of -2.81%. That is a compound annual growth rate of -0.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 1.80B | -32.56% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 1.90B |
| Keros Therapeutics | 1.89B |
| Zai Lab | 1.87B |
| Kiniksa Pharmaceuticals | 1.83B |
| Veracyte | 1.81B |
| Verona Pharma | 1.78B |
| Edgewise Therapeutics | 1.77B |
| Soleno Therapeutics | 1.77B |